$11.70
0.09%
NYSE, Sep 29, 10:17 am EDT. Market open.
ISIN
US58470H1014
Symbol
MED

Medifast Inc Target price 2026 - Analyst rating & recommendation

Medifast Inc Classifications & Recommendation

Hold
44%
Sell
56%

Medifast Inc Price Target

Target Price $12.24
Price $11.71
Potential
Number of Estimates 2
2 Analysts have issued a price target Medifast Inc 2027 . The average Medifast Inc target price is $12.24. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 0 Analysts recommend Medifast Inc to buy, 4 to hold and 5 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medifast Inc stock has an average upside potential 2027 of . Most analysts recommend the Medifast Inc stock at Sale.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 385.79 290.58
35.96% 24.68%
EBITDA Margin 0.01% -0.63%
99.85% 8,201.59%
Net Margin -4.84% -6.37%
1,495.00% 31.63%

2 Analysts have issued a sales forecast Medifast Inc 2026 . The average Medifast Inc sales estimate is

$291m
unlock
. This is
8.31% lower
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$302m 4.68%
unlock
, the lowest is
$282m 11.04%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $386m 35.96%
2026
$291m 24.68%
unlock
2027
$276m 4.87%
unlock

2 Analysts have issued an Medifast Inc EBITDA forecast 2026. The average Medifast Inc EBITDA estimate is

$-1.8m
unlock
. This is
67.88% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-1.9m 66.61%
unlock
, the lowest is
$-1.8m 68.83%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $30.0k 99.91%
2026
$-1.8m 6,160.00%
unlock
2027
$14.5m 900.00%
unlock

EBITDA Margin

2025 0.01% 99.85%
2026
-0.63% 8,201.59%
unlock
2027
5.26% 934.92%
unlock

2 Medifast Inc Analysts have issued a net profit forecast 2026. The average Medifast Inc net profit estimate is

$-18.5m
unlock
. This is
27.66% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-18.0m 29.80%
unlock
, the lowest is
$-19.3m 24.80%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-18.7m 993.30%
2026
$-18.5m 0.80%
unlock
2027
$-3.2m 82.94%
unlock

Net Margin

2025 -4.84% 1,495.00%
2026
-6.37% 31.63%
unlock
2027
-1.14% 82.10%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.70 -1.66
994.74% 2.35%
P/E negative
EV/Sales negative

2 Analysts have issued a Medifast Inc forecast for earnings per share. The average Medifast Inc EPS is

$-1.66
unlock
. This is
27.51% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-1.72 24.89%
unlock
, the lowest is
$-1.61 29.69%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.70 994.74%
2026
$-1.66 2.35%
unlock
2027
$-0.28 83.13%
unlock

P/E ratio

Current -5.11 112.31%
2026
-7.07 38.26%
unlock
2027
-41.41 485.71%
unlock

Based on analysts' sales estimates for 2026, the Medifast Inc stock is valued at an EV/Sales of

-0.13
unlock
and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -0.12 500.00%
2026
-0.13 11.50%
unlock
2027
-0.14 5.16%
unlock

P/S ratio

Current 0.41 31.73%
2026
0.45 9.08%
unlock
2027
0.47 5.10%
unlock

Current Medifast Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Stephens & Co.
Locked
➜
Locked
Locked Feb 19 2026
DA Davidson
Locked
➜
Locked
Locked Feb 19 2025
DA Davidson
Locked
➜
Locked
Locked Nov 05 2024
Analyst Rating Date
Locked
Stephens & Co.:
Locked
➜
Locked
Feb 19 2026
Locked
DA Davidson:
Locked
➜
Locked
Feb 19 2025
Locked
DA Davidson:
Locked
➜
Locked
Nov 05 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today